TI
LXRX icon

Trexquant Investment’s Lexicon Pharmaceuticals LXRX Stock Holding History

Trexquant Investment’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-14,563
Closed -$92K – 1002
2019
Q2 		$92K Buy
+14,563
New +$87.2K 0.01% 748
2019
Q1 		– Sell
-10,117
Closed -$67K – 1164
2018
Q4 		$67K Sell
10,117
-7,364
-42% -$59.7K ﹤0.01% 999
2018
Q3 		$187K Sell
17,481
-2,195
-11% -$25.2K 0.01% 838
2018
Q2 		$236K Sell
19,676
-1,007
-5% -$10.3K 0.02% 744
2018
Q1 		$177K Buy
+20,683
New +$191K 0.01% 965
2017
Q2 		– Sell
-22,535
Closed -$323K – 1003
2017
Q1 		$323K Buy
+22,535
New +$334K 0.04% 725

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Trexquant Investment's LXRX Position: Q3 2019 in Review

Trexquant Investment sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2019, closing a stake of 14,563 shares — an estimated $92K sold.

Trexquant Investment first reported a position in LXRX in Q1 2017 and held it in 6 quarters. The position peaked at $323K in Q1 2017. 103 funds tracked by Wall St. Rank hold LXRX as of Q3 2019.

  • Trexquant Investment reported no remaining Lexicon Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Trexquant Investment sold 14,563 Lexicon Pharmaceuticals shares in Q3 2019, an estimated $92K.
  • Trexquant Investment first reported a position in Lexicon Pharmaceuticals in Q1 2017 and held it in 6 quarters.
  • Trexquant Investment's Lexicon Pharmaceuticals position peaked at $323K in Q1 2017.
  • 103 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2019.

Based on Trexquant Investment's 13F filing for Q3 2019, filed 8 Nov 2019.